Bone mineral density loss in clinically suspect arthralgia is associated with subclinical inflammation and progression to clinical arthritis.

MLA

Mangnus, L., et al. “Bone Mineral Density Loss in Clinically Suspect Arthralgia Is Associated with Subclinical Inflammation and Progression to Clinical Arthritis.” Scandinavian Journal of Rheumatology, vol. 46, no. 5, Sept. 2017, pp. 364–68. EBSCOhost, https://doi.org/10.1080/03009742.2017.1299217.

APA

Mangnus, L., van Steenbergen, H., Reijnierse, M., Kälvesten, J., & van der Helm-Van Mil, A. (2017). Bone mineral density loss in clinically suspect arthralgia is associated with subclinical inflammation and progression to clinical arthritis. Scandinavian Journal of Rheumatology, 46(5), 364–368. https://doi.org/10.1080/03009742.2017.1299217

Chicago

Mangnus, L, Hw van Steenbergen, M Reijnierse, J Kälvesten, and Ahm van der Helm-Van Mil. 2017. “Bone Mineral Density Loss in Clinically Suspect Arthralgia Is Associated with Subclinical Inflammation and Progression to Clinical Arthritis.” Scandinavian Journal of Rheumatology 46 (5): 364–68. doi:10.1080/03009742.2017.1299217.